Federation des caisses Desjardins du Quebec’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-11,341	Closed	-$76.6K	–	2248
2020 Q2	$76.6K	Hold	11,341	–	–	﹤0.01%	1108
2020 Q1	$36.5K	Hold	11,341	–	–	﹤0.01%	1339
2019 Q4	$79.2K	Buy	+11,341	New	+$60.5K	﹤0.01%	1384

Other funds holding RVLP

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's RVLP Position: Q3 2020 in Review

Federation des caisses Desjardins du Quebec sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q3 2020, closing a stake of 11,341 shares — an estimated $76.6K sold.

Federation des caisses Desjardins du Quebec first reported a position in RVLP in Q4 2019 and held it in 3 quarters. The position peaked at $79.2K in Q4 2019. 62 funds tracked by Wall St. Rank hold RVLP as of Q3 2020.

Federation des caisses Desjardins du Quebec reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q3 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 11,341 RVL Pharmaceuticals plc Ordinary Shares shares in Q3 2020, an estimated $76.6K.
Federation des caisses Desjardins du Quebec first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's RVL Pharmaceuticals plc Ordinary Shares position peaked at $79.2K in Q4 2019.
62 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q3 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2020, filed 30 Aug 2024.